A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression

被引:74
|
作者
Blumberger, Daniel M. [1 ]
Mulsant, Benoit H. [1 ]
Fitzgerald, Paul B. [2 ,3 ]
Rajji, Tarek K. [1 ]
Ravindran, Arun V. [1 ]
Young, L. Trevor [1 ]
Levinson, Andrea J. [1 ]
Daskalakis, Zafiris J. [1 ,1 ]
机构
[1] Univ Toronto, Ctr Addict & Mental Hlth, Dept Psychiat, Toronto, ON, Canada
[2] The Alfred, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia
[3] Monash Univ, Dept Psychol Med, Melbourne, Vic 3004, Australia
来源
基金
加拿大健康研究院; 英国医学研究理事会;
关键词
Depression; transcranial magnetic stimulation; treatment resistance; elderly; clinical trial; DORSOLATERAL PREFRONTAL CORTEX; ASTERISK-D REPORT; FAILED MEDICATION TREATMENTS; MOTOR CORTICAL EXCITABILITY; CONTROLLED-TRIAL; ANTIDEPRESSANT RESPONSE; GLUCOSE-METABOLISM; RTMS; EFFICACY; SAFETY;
D O I
10.3109/15622975.2011.579163
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objectives. High frequency left-sided (HFL) and low frequency right-sided (LFR) unilateral repetitive transcranial magnetic stimulation (rTMS) are efficacious in treatment-resistant major depression (TRD). Similar benefit has been suggested for sequential bilateral rTMS (LFR then HFL). There are few published reports on the efficacy of sequential bilateral rTMS compared to HFL and sham rTMS. Therefore, this study evaluated the efficacy of HFL and sequential bilateral rTMS compared to sham in TRD. Methods. Subjects between the ages of 18 and 85 were recruited from a tertiary care university hospital. Seventy-four subjects with TRD and a 17-item Hamilton Depression Rating Scale (HDRS) greater than 21 were randomized to receive unilateral, bilateral, or sham rTMS. The rates of remission were compared among the three treatment groups. Results. The remission rates differed significantly among the three treatment groups using a modified intention to treat analysis that excluded subjects who did not respond to electroconvulsive therapy (ECT) during the current episode. The remission rate was significantly higher in the bilateral group than the sham group. The remission rate in the unilateral group did not differ from either group. Conclusion. These findings warrant larger controlled studies that compare the efficacy of sequential bilateral rTMS and HFL rTMS in TRD.
引用
收藏
页码:423 / 435
页数:13
相关论文
共 50 条
  • [1] Transcranial Direct Current Stimulation for Treatment-Resistant Major Depression: A Double-Blind Randomized Sham-Controlled Trial
    Sharafi, Elham
    Taghva, Arsia
    Arbabi, Mohammad
    Dadarkhah, Afsaneh
    Ghaderi, Jamshid
    [J]. CLINICAL EEG AND NEUROSCIENCE, 2019, 50 (06) : 375 - 382
  • [2] Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial
    Croarkin, Paul E.
    Elmaadawi, Ahmed Z.
    Aaronson, Scott T.
    Schrodt, G. Randolph, Jr.
    Holbert, Richard C.
    Verdoliva, Sarah
    Heart, Karen L.
    Demitrack, Mark A.
    Strawn, Jeffrey R.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2021, 46 (02) : 462 - 469
  • [3] Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial
    Paul E. Croarkin
    Ahmed Z. Elmaadawi
    Scott T. Aaronson
    G. Randolph Schrodt
    Richard C. Holbert
    Sarah Verdoliva
    Karen L. Heart
    Mark A. Demitrack
    Jeffrey R. Strawn
    [J]. Neuropsychopharmacology, 2021, 46 : 462 - 469
  • [4] Repetitive transcranial magnetic stimulation as an augmentative strategy for treatment-resistant depression, a meta-analysis of randomized, double-blind and sham-controlled study
    Liu, Bangshan
    Zhang, Yan
    Zhang, Li
    Li, Lingjiang
    [J]. BMC PSYCHIATRY, 2014, 14
  • [5] Repetitive transcranial magnetic stimulation as an augmentative strategy for treatment-resistant depression, a meta-analysis of randomized, double-blind and sham-controlled study
    Bangshan Liu
    Yan Zhang
    Li Zhang
    Lingjiang Li
    [J]. BMC Psychiatry, 14
  • [6] Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression. A double-blind, randomised, sham-controlled trial
    Bretlau, L. G.
    Lunde, M.
    Lindberg, L.
    Unden, M.
    Dissing, S.
    Bech, P.
    [J]. PHARMACOPSYCHIATRY, 2008, 41 (02) : 41 - 47
  • [7] The priming effect of repetitive transcranial magnetic stimulation on clinical response to electroconvulsive therapy in treatment-resistant depression: a randomized, double-blind, sham-controlled study
    Rotharmel, Maud
    Quesada, Pierre
    Husson, Thomas
    Harika-Germaneau, Ghina
    Nathou, Clement
    Guehl, Julien
    Dalmont, Marine
    Opolczynski, Gaelle
    Mirea-Grivel, Iris
    Millet, Bruno
    Gerardin, Emmanuel
    Compere, Vincent
    Dollfus, Sonia
    Jaafari, Nemat
    Benichou, Jacques
    Thill, Caroline
    Guillin, Olivier
    Moulier, Virginie
    [J]. PSYCHOLOGICAL MEDICINE, 2023, 53 (05) : 2060 - 2071
  • [8] Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial
    Matsuda, Yuki
    Kito, Shinsuke
    Igarashi, Yoshio
    Shigeta, Masahiro
    [J]. NEUROPSYCHOBIOLOGY, 2020, 79 (03) : 208 - 213
  • [9] Repetitive Transcranial Magnetic Stimulation in Delirium: A Double-Blind, Randomized, Sham-Controlled, Pilot Study
    Yaghoubi, Emad
    Shariat, Seyed Vahid
    Rashedi, Vahid
    Jolfaei, Atefeh Ghanbari
    [J]. BASIC AND CLINICAL NEUROSCIENCE, 2022, 13 (02) : 237 - 246
  • [10] Double-blind controlled investigation of bilateral prefrontal transcranial magnetic stimulation for the treatment of resistant major depression
    Loo, CK
    Mitchell, PB
    Croker, VM
    Malhi, GS
    Wen, W
    Gandevia, SC
    Sachdev, PS
    [J]. PSYCHOLOGICAL MEDICINE, 2003, 33 (01) : 33 - 40